• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biochim Biophys Acta Mol Basis Dis . Neutrophils shape the therapeutic efficacy of sirtuin 1 activity modulators in murine influenza virus infection

tetano

Editor, Senior Moderator
Biochim Biophys Acta Mol Basis Dis


. 2025 May 24:167915.
doi: 10.1016/j.bbadis.2025.167915. Online ahead of print. Neutrophils shape the therapeutic efficacy of sirtuin 1 activity modulators in murine influenza virus infection

Lora Simeonova[SUP] 1 [/SUP], Milena Leseva[SUP] 2 [/SUP], Kalin Stoyanov[SUP] 3 [/SUP], Antonello Mai[SUP] 4 [/SUP], Luciano Saso[SUP] 5 [/SUP], Petya Dimitrova[SUP] 6 [/SUP]



Affiliations
Abstract

Sirtuin 1 (Sirt1), a class III histone deacetylase, is a key regulator of gene expression in various immune cell types, including neutrophils, during infection and acute inflammation. Herein, we studied the effect of the Sirt1 activator (SRT2183) and inhibitor (EX527) on the neutrophil pools in the bronchoalveolar lavage fluid (BAL), lung, blood and bone marrow (BM) in mild and severe influenza A virus (IAV) infection. We defined the correlation between parameters characteristic for neutrophil migration, their functional state and the infection-induced lung injury. SRT2183 had a protective effect in mild IAV infection but it failed to improve the lung pathology in severe IAV infection. The infection-induced lung injury in the SRT2183-treated group correlated positively with the counts of lung Ly6G[SUP]+[/SUP] cells, the frequency of BAL Ly6G[SUP]+[/SUP] producing interleukin (IL)-1β and tumor-necrosis factor (TNF)-α and the C-X-C chemokine receptor (CXCR) 2 on blood neutrophils, and correlated negatively with the BM Ly6G[SUP]+[/SUP] cell counts and the expression of CXCR2 on lung neutrophils as well as there was no correlation between BAL Ly6G[SUP]+[/SUP]IL-1β[SUP]+[/SUP] cells and BAL and lung neutrophils with aged phenotype. The lung pathology in EX527-treated group with infection was strongly associated with the BAL Ly6G[SUP]+[/SUP]TNF-α[SUP]+[/SUP] cells and the Sirt1 levels in Ly6G[SUP]hi[/SUP] neutrophils. Overall, the results showed that although the Sirt1 activator had a greater effect in normalizing the BM and blood neutrophils in severe IAV infection, its effectiveness was compromised locally by its failure to inhibit the expanded neutrophil pools to a degree that was less detrimental.

Keywords: EX527; Influenza infection; Interleukin (IL)-1β; Lung; Neutrophils; SRT2183; Sirtuin 1.

 
Back
Top Bottom